489 related articles for article (PubMed ID: 24176748)
1. Structural characterization of in vitro metabolites of the new anticancer agent EAPB0503 by liquid chromatography-tandem mass spectrometry.
Lafaille F; Solassol I; Enjalbal C; Bertrand B; Doulain PE; Vappiani J; Bonnet PA; Deleuze-Masquéfa C; Bressolle FM
J Pharm Biomed Anal; 2014 Jan; 88():429-40. PubMed ID: 24176748
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studies.
Lafaille F; Banaigs B; Inguimbert N; Enjalbal C; Doulain PE; Bonnet PA; Masquefa C; Bressolle FM
Anal Chem; 2012 Nov; 84(22):9865-72. PubMed ID: 23072539
[TBL] [Abstract][Full Text] [Related]
3. In vivo metabolic investigation of moxifloxacin using liquid chromatography/electrospray ionization tandem mass spectrometry in combination with online hydrogen/deuterium exchange experiments.
Raju B; Ramesh M; Borkar RM; Srinivas R; Padiya R; Banerjee SK
Rapid Commun Mass Spectrom; 2012 Aug; 26(16):1817-31. PubMed ID: 22777784
[TBL] [Abstract][Full Text] [Related]
4. Structural elucidation of in vitro metabolites of emodin by liquid chromatography-tandem mass spectrometry.
Song R; Xu F; Zhang Z; Liu Y; Dong H; Tian Y
Biomed Chromatogr; 2008 Nov; 22(11):1230-6. PubMed ID: 18651591
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and pharmacokinetics of EAPB0203 and EAPB0503, two imidazoquinoxaline compounds previously shown to have antitumoral activity on melanoma and T-lymphomas.
Khier S; Gattacceca F; El Messaoudi S; Lafaille F; Deleuze-Masquéfa C; Bompart J; Cooper JF; Solassol I; Pinguet F; Bonnet PA; Bressolle FM
Drug Metab Dispos; 2010 Oct; 38(10):1836-47. PubMed ID: 20660102
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MS.
Khier S; Moarbess G; Deleuze-Masquefa C; Solassol I; Margout D; Pinguet F; Bonnet PA; Bressolle FM
J Sep Sci; 2009 May; 32(9):1363-73. PubMed ID: 19399864
[TBL] [Abstract][Full Text] [Related]
7. Metabolite identification of a new tyrosine kinase inhibitor, HM781-36B, and a pharmacokinetic study by liquid chromatography/tandem mass spectrometry.
Kim E; Kim H; Suh K; Kwon S; Lee G; Park NH; Hong J
Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1183-95. PubMed ID: 23650031
[TBL] [Abstract][Full Text] [Related]
8. Identification and structural characterization of in vivo metabolites of ketorolac using liquid chromatography electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS).
Raju B; Ramesh M; Borkar RM; Padiya R; Banerjee SK; Srinivas R
J Mass Spectrom; 2012 Jul; 47(7):919-31. PubMed ID: 22791260
[TBL] [Abstract][Full Text] [Related]
9. Fragmentation study on the phenolic alkaloid neferine and its analogues with anti-HIV activities by electrospray ionization tandem mass spectrometry with hydrogen/deuterium exchange and its application for rapid identification of in vitro microsomal metabolites of neferine.
Zhou H; Jiang H; Yao T; Zeng S
Rapid Commun Mass Spectrom; 2007; 21(13):2120-8. PubMed ID: 17546644
[TBL] [Abstract][Full Text] [Related]
10. Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study.
Bandu R; Ahn HS; Lee JW; Kim YW; Choi SH; Kim HJ; Kim KP
PLoS One; 2015; 10(8):e0134027. PubMed ID: 26244343
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
[TBL] [Abstract][Full Text] [Related]
12. Identification of BVT.2938 metabolites by LC/MS and LC/MS/MS after in vitro incubations with liver microsomes and hepatocytes.
Edlund PO; Baranczewski P
J Pharm Biomed Anal; 2004 Mar; 34(5):1079-90. PubMed ID: 15019042
[TBL] [Abstract][Full Text] [Related]
13. Analysis of furo[3,2-c]tetrahydroquinoline and pyrano[3,2-c]tetrahydroquinoline derivatives as antitumor agents and their metabolites by liquid chromatography/electrospray ionization tandem mass spectrometry.
Hou X; Luo H; Zhong H; Wu F; Zhou M; Zhang W; Han X; Yan G; Zhang M; Lu L; Ding Z; He G; Li R
Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1222-30. PubMed ID: 23650035
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism of ethoxidine by human CYP1A1 and rat microsomes: identification of metabolites by high-performance liquid chromatography combined with electrospray tandem mass spectrometry and accurate mass measurements by time-of-flight mass spectrometry.
Deroussent A; Ré M; Hoellinger H; Vanquelef E; Duval O; Sonnier M; Cresteil T
Rapid Commun Mass Spectrom; 2004; 18(4):474-82. PubMed ID: 14966856
[TBL] [Abstract][Full Text] [Related]
15. Identification of in vivo and in vitro metabolites of triptolide by liquid chromatography-tandem mass spectrometry.
Peng ZH; Wang JJ; Du P; Chen Y
J Pharm Biomed Anal; 2012 Nov; 70():624-30. PubMed ID: 22824635
[TBL] [Abstract][Full Text] [Related]
16. Characterization of in vitro metabolites of TM-2, a potential antitumor drug, in rat, dog and human liver microsomes using liquid chromatography/tandem mass spectrometry.
Men L; Zhao Y; Lin H; Yang M; Liu H; Tang X; Yu Z
Rapid Commun Mass Spectrom; 2014 Oct; 28(20):2162-70. PubMed ID: 25178720
[TBL] [Abstract][Full Text] [Related]
17. Metabolite identification of artemether by data-dependent accurate mass spectrometric analysis using an LTQ-Orbitrap hybrid mass spectrometer in combination with the online hydrogen/deuterium exchange technique.
Liu T; Du F; Zhu F; Xing J
Rapid Commun Mass Spectrom; 2011 Nov; 25(21):3303-13. PubMed ID: 22006394
[TBL] [Abstract][Full Text] [Related]
18. Application of electrospray ionization hybrid ion trap/time-of-flight mass spectrometry in the rapid characterization of quinocetone metabolites formed in vitro.
Liu ZY; Huang LL; Chen DM; Dai MH; Tao YF; Wang YL; Yuan ZH
Anal Bioanal Chem; 2010 Feb; 396(3):1259-71. PubMed ID: 20020112
[TBL] [Abstract][Full Text] [Related]
19. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
20. In vitro pharmacokinetic profile of a benzopyridooxathiazepine derivative using rat microsomes and hepatocytes: identification of phases I and II metabolites.
Bourdon F; Lecoeur M; Verones V; Vaccher C; Lebegue N; Dine T; Kambia N; Goossens JF
J Pharm Biomed Anal; 2013 Jun; 80():69-78. PubMed ID: 23528331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
